HNGE Rule 144: Insight Venture reports multiple Class A sales

Hinge Health, Inc. related parties filed notices under Rule 144 reporting proposed sales of Class A Common shares.

Rhea-AI Filing Summary

Hinge Health, Inc. related parties filed notices under Rule 144 reporting proposed sales of Class A Common shares. The excerpt lists several transactions by Insight Venture Partners X, L.P. on 06/16/2026 through 06/25/2026, showing individual sale quantities and gross proceeds for each trade date.

The filings name a broker-dealer (Raymond James & Associates) and reference earlier securities (Series B preferred converted before IPO). These are routine Rule 144 resale notices reporting trades by an institutional holder; timing and cumulative totals beyond the listed rows are not aggregated in the excerpt.

Insights

Securities Attorney

Routine Rule 144 resale notices for institutional holder; no novel disclosures.

These entries document proposed sales of Class A Common shares by Insight Venture Partners X, L.P. on specified dates between 06/16/2026 and 06/25/2026. Each row shows the number of shares and associated gross proceeds per trade date.

Cash-flow treatment to issuer is not stated. Timing and aggregate selling limits under Rule 144 are not included in the excerpt; subsequent filings or broker confirmations would show settlement details.

Equity Markets Analyst

Multiple block trades reported by a single institutional holder over consecutive days.

The excerpt lists five discrete sale events by the same holder across consecutive dates with specific share counts and gross proceeds per trade. The broker-dealer named is Raymond James & Associates.

This pattern is consistent with staged resale execution; the excerpt does not state any lock-up expiration, volume limits, or post-transaction holdings.

Key Figures

Sale 06/16/2026: 32,751 shares for $2,304,347.26 Sale 06/22/2026: 112,064 shares for $7,951,400.26 Sale 06/23/2026: 56,171 shares for $3,944,018.68 +3 more

6 metrics

Sale 06/16/2026 32,751 shares for $2,304,347.26 trade dated <date>06/16/2026</date>

Sale 06/22/2026 112,064 shares for $7,951,400.26 trade dated <date>06/22/2026</date>

Sale 06/23/2026 56,171 shares for $3,944,018.68 trade dated <date>06/23/2026</date>

Sale 06/24/2026 266,290 shares for $18,963,363.03 trade dated <date>06/24/2026</date>

Sale 06/25/2026 265,169 shares for $19,045,365.67 trade dated <date>06/25/2026</date>

Securities referenced Series B Preferred (converted) and Class A Common Historical conversion noted <date>07/03/2018</date>

Key Terms

Rule 144, Class A Common, Series B Preferred Stock, Broker-dealer (Raymond James & Associates)

4 terms

Rule 144 regulatory

"144: Securities Sold During The Past 3 Months"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Class A Common financial

"CLASS A COMMON | RAYMOND JAMES & ASSOCIATES"

Series B Preferred Stock financial

"SERIES B PREFFERED STOCK | 07/03/2018 | STOCK CONVERSION BEFORE IPO"

Series B preferred stock is a type of ownership share issued by a company that offers certain advantages over common stock, such as priority in receiving dividends or assets if the company is sold or liquidated. It is typically issued after an initial round of funding, making it a way for investors to support a company's growth while gaining some protections and benefits. This stock matters to investors because it often provides a more secure investment position with potential for future growth.

Broker-dealer (Raymond James & Associates) regulatory

"RAYMOND JAMES & ASSOCIATES 880 CARILLON PKWY"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for HNGE show about Insight Venture Partners' trades?

It lists proposed sales of Class A Common shares by Insight Venture Partners X, L.P.. The excerpt shows five dated trades from 06/16/2026 to 06/25/2026 with share counts and gross proceeds for each date.

Which broker-dealer is named in the HNGE Rule 144 notice?

The filing names Raymond James & Associates at 880 Carillon Pkwy, St. Petersburg, FL. That broker-dealer appears in the securities-to-be-sold section of the excerpt but settlement details are not provided.

How many shares and proceeds were reported on 06/24/2026 in the excerpt?

The excerpt reports 266,290 shares sold on 06/24/2026 with gross proceeds of $18,963,363.03, as shown in the sale-row for that date.

Does the excerpt indicate conversion history for any securities?

Yes. The excerpt references Series B Preferred Stock with note “STOCK CONVERSION BEFORE IPO” dated 07/03/2018, indicating historical conversion activity recorded in the filing text.

Are aggregate totals or post-transaction holdings provided in this excerpt?

No. The excerpt lists per-date share counts and gross proceeds for individual trades but does not provide an aggregate total or the selling holder’s post-transaction holdings in the provided rows.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 04:55 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001710959
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 MARKET STREET 7TH FLOOR SAN FRANCISCO CALIFORNIA 94105
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Insight Venture Partners X, L.P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
CLASS A COMMON	RAYMOND JAMES & ASSOCIATES 880 CARILLON PKWY ST. PETERSBURG FL 33716	732444	58595520.00	55883690	06/29/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
SERIES B PREFFERED STOCK	07/03/2018	STOCK CONVERSION BEFORE IPO	HINGE HEALTH, INC.			106729	07/03/2018	WIRED TO PORTFOLIO COMPANY

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Insight Venture Partners X, L.P. 1114 Avenue of the Americas, 36th Floor NEW YORK NY 10036	CLASS A COMMON	06/16/2026	32751	2304347.26
Insight Venture Partners X, L.P. 1114 AVENUE OF AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/22/2026	112064	7951400.26
Insight Venture Partners X, L.P. 1114 AVENUE OF AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/23/2026	56171	3944018.68
Insight Venture Partners X, L.P. 1114 AVENUE OF THE AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/24/2026	266290	18963363.03
Insight Venture Partners X, L.P. 1114 AVENUE OF THE AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/25/2026	265169	19045365.67

144: Remarks and Signature

Remarks
Date of Notice	06/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	MOHAMMED ALSHATRI, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Insight Venture Partners X, L.P.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)